We are live on
!
Find out more
VOYA Investment Management Portfolio holdings
AUM
$116B
1-Year Est. Return
61.47%
This Fund
S&P 500
This Quarter
Est. Return
+6.26%
1 Year Est. Return
+61.47%
3 Year Est. Return
+172.42%
5 Year Est. Return
+231.94%
10 Year Est. Return
+892.64%
AUM
$96.7B
AUM Growth
-$4.91B
(-4.8%)
Cap. Flow
-$19.4B
Cap. Flow
% of AUM
-20.03%
Top 10 Holdings %
Top 10 Hldgs %
24.57%
Holding
2,878
New
61
Increased
764
Reduced
1,806
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$300M |
| 3 |
PayPal
PYPL
|
+$241M |
| 4 |
Intuitive Surgical
ISRG
|
+$232M |
| 5 |
HPE.PRC
Hewlett Packard Enterprise 7.625% Series C Preferred Stock
HPE.PRC
|
+$201M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$874M |
| 2 |
Amazon
AMZN
|
+$807M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$667M |
| 4 |
Microsoft
MSFT
|
+$594M |
| 5 |
ASML
ASML
|
+$394M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.93% |
| 2 | Healthcare | 9.84% |
| 3 | Consumer Discretionary | 8.91% |
| 4 | Financials | 8.66% |
| 5 | Industrials | 7.17% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLFY
2501
DELISTED
Blue Foundry Bancorp
BLFY
| $113K | ﹤0.01% |
11,016
+280
| +3% | +$2.91K |
|
2502
Garrett Motion
GTX
$5.45B
| $112K | ﹤0.01% |
13,746
| – | – |
|
2503
Theravance Biopharma
TBPH
$879M
| $112K | ﹤0.01% |
13,903
-2,979
| -18% | -$25.8K |
|
|
TRUE
2504
DELISTED
TrueCar
TRUE
| $112K | ﹤0.01% |
32,360
+159
| +0.5% | +$510 |
|
2505
Nano X Imaging
NNOX
$74.5M
| $112K | ﹤0.01% |
18,355
+79
| +0.4% | +$561 |
|
2506
C4 Therapeutics
CCCC
$480M
| $111K | ﹤0.01% |
19,481
-254
| -1% | -$1.53K |
|
2507
Taysha Gene Therapies
TSHA
$2.02B
| $111K | ﹤0.01% |
55,044
+1,110
| +2% | +$2.44K |
|
|
OLPX
2508
DELISTED
Olaplex Holdings
OLPX
| $110K | ﹤0.01% |
46,744
-1,254
| -3% | -$2.54K |
|
2509
Corsair Gaming
CRSR
$1.4B
| $110K | ﹤0.01% |
15,743
-6
| -0% | -$45 |
|
2510
Pulmonx
LUNG
$97.9M
| $110K | ﹤0.01% |
13,216
+156
| +1% | +$1.13K |
|
2511
Sutro Biopharma
STRO
$369M
| $109K | ﹤0.01% |
3,153
+356
| +13% | +$14K |
|
2512
AngioDynamics
ANGO
$654M
| $109K | ﹤0.01% |
13,955
+108
| +0.8% | +$780 |
|
|
FNA
2513
DELISTED
Paragon 28, Inc.
FNA
| $108K | ﹤0.01% |
16,156
+127
| +0.8% | +$962 |
|
|
IAUX
2514
i-80 Gold Corp
IAUX
$1.52B
| $107K | ﹤0.01% |
92,536
+1,583
| +2% | +$1.66K |
|
|
NAPA
2515
DELISTED
The Duckhorn Portfolio, Inc.
NAPA
| $107K | ﹤0.01% |
18,415
+317
| +2% | +$2.09K |
|
2516
SIGA Technologies
SIGA
$208M
| $107K | ﹤0.01% |
15,835
-17
| -0.1% | -$148 |
|
2517
Designer Brands
DBI
$314M
| $106K | ﹤0.01% |
14,391
+38
| +0.3% | +$266 |
|
2518
Navitas Semiconductor
NVTS
$3.68B
| $106K | ﹤0.01% |
43,251
+632
| +1% | +$2.05K |
|
|
PHLT
2519
DELISTED
Performant Healthcare Inc
PHLT
| $106K | ﹤0.01% |
28,303
-176
| -0.6% | -$601 |
|
2520
Allogene Therapeutics
ALLO
$725M
| $105K | ﹤0.01% |
37,371
+1,501
| +4% | +$4K |
|
|
ESPR
2521
DELISTED
Esperion Therapeutics
ESPR
| $104K | ﹤0.01% |
63,142
+113
| +0.2% | +$228 |
|
2522
Zevra Therapeutics
ZVRA
$681M
| $104K | ﹤0.01% |
14,999
-1,400
| -9% | -$9.5K |
|
2523
Atea Pharmaceuticals
AVIR
$412M
| $104K | ﹤0.01% |
30,974
-339
| -1% | -$1.23K |
|
2524
Radiant Logistics
RLGT
$399M
| $103K | ﹤0.01% |
16,078
+532
| +3% | +$3.24K |
|
2525
Absci
ABSI
$1.56B
| $102K | ﹤0.01% |
26,709
-512
| -2% | -$2.04K |
|
Similar funds
VAM
VOYA Investment Management's Q3 2024 Portfolio in Review
As of Q3 2024, VOYA Investment Management held 2,878 positions worth $96.7B, down 4.8% from $102B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
VOYA Investment Management withdrew a net $19.4B in Q3 2024, closing 67 positions and reducing 1,806 holdings. Its most notable exit was Vanguard Short-Term Corporate Bond ETF, an estimated $80.7M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 35% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, VOYA Investment Management opened a new position in Hewlett Packard Enterprise 7.625% Series C Preferred Stock worth $208M.
- VOYA Investment Management's largest Q3 2024 buy was Hewlett Packard Enterprise 7.625% Series C Preferred Stock: 3,432,500 shares worth $208M.
- VOYA Investment Management added most to UnitedHealth in Q3 2024, an estimated $363M increase.
- VOYA Investment Management's biggest Q3 2024 reduction was Apple, cutting an estimated $874M.
- VOYA Investment Management fully exited Vanguard Short-Term Corporate Bond ETF in Q3 2024, selling an estimated $80.7M.
- VOYA Investment Management's ten largest holdings make up 25% of its $96.7B portfolio in Q3 2024.
- VOYA Investment Management opened 61 new positions and closed 67 in Q3 2024.
- VOYA Investment Management's portfolio value fell 4.8% quarter-over-quarter to $96.7B.
Based on VOYA Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.